Your body breaks up blood clots on its own through a built-in dissolving system, and when that’s not enough, doctors use clot-busting drugs, physical extraction devices, or a combination of both. Which approach applies depends on where the clot is, how large it is, and how much danger it poses. Here’s how each method works.
How Your Body Dissolves Clots Naturally
Your bloodstream has its own clot-removal system called fibrinolysis. When a clot has done its job and a wound has healed, cells lining your blood vessels release an activating enzyme that kicks off the cleanup. This enzyme converts a protein called plasminogen, which circulates in your blood at all times, into its active form: plasmin. Plasmin then cuts the mesh-like structure of the clot into small, soluble fragments that wash away in the bloodstream.
The process has a built-in accelerator. Once a small amount of plasmin forms, it triggers a positive feedback loop that generates more plasmin, speeding up dissolution. Your body also has braking mechanisms (proteins that neutralize plasmin) to prevent the system from dissolving clots you still need. When formation and breakdown stay in balance, clots form where they’re needed and disappear when they’re not. Problems arise when a clot forms in the wrong place, grows too large, or your natural dissolving system can’t keep up.
Doctors can actually measure this process with a blood test called D-dimer. When plasmin chops up a clot, it produces a specific fragment called D-dimer. Elevated D-dimer levels in your blood signal that clots are actively forming and breaking down somewhere in your body, which helps doctors decide whether to investigate further for conditions like deep vein thrombosis or pulmonary embolism.
Clot-Busting Drugs (Thrombolytics)
When a dangerous clot blocks blood flow to the brain, heart, or lungs, doctors can use powerful medications that supercharge the body’s natural dissolving process. These drugs, called thrombolytics, work by rapidly converting plasminogen into plasmin, the same clot-cutting enzyme your body makes on its own. The difference is speed and intensity: thrombolytics flood the area with far more dissolving power than your body could produce alone.
The most widely used thrombolytic is alteplase, a lab-made version of the activating enzyme your blood vessel walls naturally produce. It’s the preferred drug for acute ischemic stroke (a stroke caused by a clot blocking a brain artery), and it’s also used for heart attacks and pulmonary embolisms. Other thrombolytics like tenecteplase and reteplase are commonly used for heart attacks across the U.S. and Europe.
Timing is critical. For ischemic stroke, alteplase generally needs to be given within 4.5 hours of symptom onset. For heart attacks, the sooner treatment begins, the more heart muscle is saved. This is why “time is brain” and “time is muscle” are common refrains in emergency medicine.
Risks of Thrombolytics
Because these drugs amplify clot breakdown throughout the body, not just at the dangerous clot, bleeding is the main risk. In a large analysis of over 40,000 heart attack patients treated with thrombolytics, 1.2% experienced severe bleeding and 11.4% had moderate bleeding. Across a broader review of nearly 58,600 patients, thrombolytic therapy carried a 1.1% rate of major life-threatening or transfusion-requiring bleeding, compared to 0.4% in patients who didn’t receive the drugs. Intracranial hemorrhage (bleeding in the brain) is the most feared complication, which is why doctors carefully weigh the risks before administering these medications.
Blood Thinners: Prevention, Not Removal
A common point of confusion: blood thinners (anticoagulants) like heparin and warfarin do not break up existing clots. They prevent clots from growing larger and stop new ones from forming. This gives your body’s natural dissolving system time to do its work gradually. For many clots, particularly smaller deep vein clots, this approach is sufficient. The clot slowly shrinks over weeks to months as your body’s plasmin chips away at it while the blood thinner keeps the clot from expanding.
Thrombolytics, by contrast, actively dissolve the clot within hours. The trade-off is straightforward: thrombolytics resolve the blockage fast but carry higher bleeding risk, while blood thinners are safer but rely on your body to do the dissolving over a much longer timeline. In life-threatening situations where blood flow must be restored immediately, thrombolytics or physical removal win out. For less urgent clots, blood thinners are typically the first-line treatment.
Mechanical Clot Removal
Sometimes doctors physically extract a clot rather than dissolving it chemically. This is called mechanical thrombectomy, and it’s become a standard treatment for large-vessel strokes and certain pulmonary embolisms.
The two primary techniques involve threading a thin catheter through a blood vessel (usually starting at the groin) up to the clot. A stent retriever is a small mesh device that expands inside the clot, traps it, and pulls it out when the catheter is withdrawn. Alternatively, a large-diameter catheter can suction the clot out directly, similar to a tiny vacuum. Doctors sometimes use a balloon at the tip of a guide catheter to temporarily stop blood flow, preventing clot fragments from drifting deeper into the vessel during extraction.
For pulmonary embolisms, a newer approach combines physical and chemical methods. A specialized catheter delivers ultrasound waves directly into the clot while simultaneously infusing a low dose of a thrombolytic drug. The ultrasound loosens the clot’s structure, allowing the drug to penetrate more deeply and work at lower doses than would otherwise be needed. This reduces the bleeding risk associated with higher systemic drug doses.
Nattokinase: A Dietary Enzyme
Nattokinase is an enzyme found in natto, a traditional Japanese food made from fermented soybeans. It has genuine fibrinolytic activity, meaning it can break down the same clot proteins that plasmin targets. In human studies, a single oral dose of 2,000 FU (fibrinolytic units) significantly increased clot degradation products in the blood within four hours. It also appears to boost the body’s own production of tissue plasminogen activator, the natural enzyme that starts the clot-dissolving cascade.
That said, nattokinase is a dietary supplement, not a proven medical treatment for active blood clots. Its effects are far milder than pharmaceutical thrombolytics. Researchers view it as a potentially useful tool for cardiovascular risk reduction over time, not as an emergency clot buster. If you’re on blood thinners or other cardiovascular medications, nattokinase can interact with them, so it’s worth discussing with your doctor before adding it.
What Determines Which Approach Is Used
The choice depends on the clot’s location, size, and how much immediate danger it poses. A massive clot blocking a major brain artery calls for thrombolytics, mechanical thrombectomy, or both within hours. A life-threatening pulmonary embolism may warrant catheter-based treatment with ultrasound-assisted drug delivery. A deep vein clot in the leg, if it’s not immediately threatening, is typically managed with blood thinners alone, letting the body dissolve it gradually.
Small, everyday clots that form at minor injury sites dissolve on their own without any intervention. Your body’s fibrinolytic system handles these routinely, often without you ever knowing a clot formed in the first place. The medical interventions described above are reserved for clots that your body can’t manage alone, ones that threaten organs, limbs, or life.